Quarterly report pursuant to Section 13 or 15(d)

Royalty and Commercial Payment Purchase Agreements (Tables)

v3.24.2.u1
Royalty and Commercial Payment Purchase Agreements (Tables)
6 Months Ended
Jun. 30, 2024
Royalty and Commercial Payment Purchase Agreements  
Summary of royalty and commercial payment receivable activities

The following table summarizes the royalty and commercial payment receivable activities during the six months ended June 30, 2024 (in thousands):

​

​

​

​

​

​

​

​

Short-Term

Long-Term

Balance as of January 1, 2024

    

$

14,215

$

57,952

Acquisition of royalty and commercial payment receivables:

​

​

​

​

​

Talphera

​

 

—

 

8,000

Daré

​

​

—

 

22,000

Receipt of royalty and commercial payments:

​

​

​

​

​

Viracta

​

​

—

​

(8,500)

Affitech

​

​

(7,396)

​

—

Aptevo

​

​

(794)

​

—

Talphera

​

​

—

​

(51)

Income from purchased receivables under effective interest rate method:

​

​

​

​

​

Affitech

​

​

4,562

​

—

Reclassification to short-term royalty and commercial payment receivables:

​

​

​

​

​

Aptevo

​

​

670

​

(670)

Recognition of contingent consideration:

​

​

​

​

​

Affitech

​

​

3,000

​

—

Impairment of royalty and commercial payment receivables:

​

​

​

​

​

Aronora

​

​

​

​

(9,000)

Balance as of June 30, 2024

​

$

14,257

$

69,731